Počet záznamů: 1  

Efficacy and immunogenicity of a veterinary vaccine candidate against tick-borne encephalitis in dogs

  1. 1.
    0579681 - BC 2024 RIV GB eng J - Článek v odborném periodiku
    Salát, Jiří - Huňady, M. - Svoboda, Pavel - Strelcova, L. - Straková, Petra - Fořtová, A. - Palus, Martin - Růžek, Daniel
    Efficacy and immunogenicity of a veterinary vaccine candidate against tick-borne encephalitis in dogs.
    Vaccine. Roč. 41, č. 42 (2023), s. 6150-6155. ISSN 0264-410X. E-ISSN 1873-2518
    Grant CEP: GA MŠMT(CZ) LX22NPO5103
    Institucionální podpora: RVO:60077344
    Klíčová slova: louping-ill * Tickborne encephalitis * Vaccine * Dogs
    Obor OECD: Virology
    Impakt faktor: 5.5, rok: 2022
    Způsob publikování: Omezený přístup
    https://www.sciencedirect.com/science/article/pii/S0264410X23010897?via%3Dihub

    Tick-borne encephalitis (TBE) is a severe neuroinfection of humans. Dogs are also commonly infected with tickborne encephalitis virus (TBEV). These infections are usually asymptomatic, but sometimes show clinical signs similar to those seen in humans and can be fatal. To date, there is no TBEV vaccine available for use in dogs. To address this need, a TBEV vaccine candidate for dogs based on inactivated whole virus antigen was developed. The safety, immunogenicity, and efficacy of the vaccine candidate were tested in mice as the preclinical model and in dogs as the target organism. The vaccine was well tolerated in both species and elicited the production of specific anti-TBEV antibodies with virus neutralising activity. Vaccination of mice provided complete protection against the development of fatal TBE. Immunisation of dogs prevented the development of viremia after challenge infection. Therefore, the developed vaccine candidate is promising to protect dogs from severe TBEV infections.
    Trvalý link: https://hdl.handle.net/11104/0348493

     
    Název souboruStaženoVelikostKomentářVerzePřístup
    Salat_2023_Vaccin.pdf01.2 MBVydavatelský postprintvyžádat
     
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.